Role of Immunosuppressive Regimen on the Incidence and Characteristics of Cytomegalovirus Infection in Heart Transplantation: A Single-Center Experience With Preemptive Therapy

A RANDOMIZED ACTIVE-CONTROLLED TRIAL OF MYCOPHENOLATE MOFETIL IN HEART TRANSPLANT RECIPIENTS1

Jon Kobashigawa, Dale G. Renlund, Robert M. Mentzer et al. · Transplantation · 1998 · 616 citations

Medicine, Pharmacology, Pharmacotherapy +17

Primary immune responses to human CMV: a critical role for IFN-γ–producing CD4+ T cells in protection against CMV disease

Laila E. Gamadia, Ester B. M. Remmerswaal, Jan Weel et al. · Blood · 2003 · 421 citations · Full text

Life Sciences, Immunology, Infectious Diseases +17

CYTOMEGALOVIRUS PP65 ANTIGENEMIA MONITORING AS A GUIDE FOR PREEMPTIVE THERAPY: A COST EFFECTIVE STRATEGY FOR PREVENTION OF CYTOMEGALOVIRUS DISEASE IN ADULT LIVER TRANSPLANT RECIPIENTS1

Shimon Kusne, Paolo Grossi, William H. Irish et al. · Transplantation · 1999 · 111 citations

Medicine, Infectious Diseases, Surgery +17

MYCOPHENOLATE MOFETIL VERSUS AZATHIOPRINE IN PATIENTS SURVIVING THE INITIAL CARDIAC TRANSPLANT HOSPITALIZATION: AN ANALYSIS OF THE JOINT UNOS/ISHLT THORACIC REGISTRY

Jeffrey D. Hosenpud, Leah E. Bennett · Transplantation · 2001 · 87 citations

Medicine, Cardiology, Pharmacotherapy +14

IMPROVED LONG-TERM RESULTS WITH THYMOGLOBULINE INDUCTION THERAPY AFTER CARDIAC TRANSPLANTATION: A COMPARISON OF TWO DIFFERENT RABBIT-ANTITHYMOCYTE GLOBULINES

Andreas Zuckermann, Michael Grimm, Martin Czerny et al. · Transplantation · 2000 · 62 citations

Medicine, Cardiology, Immunology +17